The global Radix Isatidis market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Radix Isatidis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Radix Isatidis market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Radix Isatidis in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Radix Isatidis manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Guangzhou Baiyun Mountain Pharmaceutical Group
Huarun 39 pharmaceuticals Limited by Share Ltd
China Beijing Tongrentang (Group) Co., Ltd.
Guangzhou Xiangxue pharmaceutical Limited by Share Ltd
Yunnan Baiyao Group Limited by Share Ltd
Revised Pharmaceutical Group Limited by Share Ltd
Jilin Aodong Pharmaceutical Group Corporation
Taiji Group Ltd
Anhui Hua Tuo national drug Limited by Share Ltd
Li Shizhen Medical Group Ltd

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Grain
Capsule
Other

Segment by Application
Pharmacy
Hospital
Other